Sign in

Colm Ryan

@colmr.bsky.social
358 followers 407 following 78 posts

Systems biology | Bioinformatics | Cancer | Genetic interactions cancerdata.ucd.ie (he / him)

PostsRepliesMedia
Colm Ryan @colmr.bsky.social · 30/09/2026
Super cool, structure-function analysis of a whole pathway using CRISPR base editing. www.biorxiv.org/content/10.6...
biorxiv.org
Structure-function analysis of PI3K signalling cascade base editing screens in cancer cells
Knowledge of protein structure and function underpins rational drug discovery, yet many targets lack known selectively druggable sites. Furthermore, the identification of secondary druggable sites off...
021
Reposted by Colm Ryan
Manuel Kaulich @manuelkaulich.bsky.social · 29/09/2026
Please join us! 78th GBM Mosbach Colloquium: Precision Cancer Medicine: From Molecular Mechanisms to Therapeutic Innovation Mosbach, Germany: Mar 17–20, 2027
 Top speakers, selected talks, posters 
Abstracts & reg: Jan 31, 2026 mosbacher-kolloquium.org/78-mosbacher...
mosbacher-kolloquium.org
78th Mosbacher Kolloquium - Mosbacher_Kolloquium.html
Mosbacher Kolloquium der Gesellschaft für Biochemie und Molekularbiologie e.V.
101
Reposted by Colm Ryan
University College Dublin @ucddublin.bsky.social · 25/09/2026
👩‍🎓📃 Analysis of almost 40,000 review reports for research funding reveals that female researchers provide longer, more positive assessments than their male counterparts and cover the formal evaluation criteria more comprehensively. 🧵 @stefanmueller.bsky.social @ucdpolitics.bsky.social
21716
Reposted by Colm Ryan
John Stott @jpsastro.bsky.social · 24/09/2026
Had a UKRI funded grant proposal rejected at the "AI triage stage". "This AI-based triage was used only to identify approximately 50% of the strongest proposals to take forward to full human review." 🧪 #academicsky
I am writing to let you know that, unfortunately, your application was not successful.

Review process

As part of the initial triage of the 179 proposals submitted to this call, each was assessed using an AI-based review. Every proposal was read independently by several different AI models against the same seven criteria used to shape this call (including cyber security relevance, research quality and novelty, importance of the problem addressed, feasibility of the project plan, likely outputs and impact, value for money, and responsible research practice), with each model asked to give a score and a written justification with supporting quotations from the text. To guard against any one model's idiosyncrasies, we also ran a second, independent process in which different AI models debated the merits and weaknesses of each proposal before reaching a judgement, again against the same criteria. Scores from both processes were combined to produce an overall ranking. 

This AI-based triage was used only to identify approximately 50% of the strongest proposals to take forward to full human review.  Projects selected for funding were drawn from those that progressed to the full human review stage. We recognise that AI-assisted assessment is a new and evolving part of the review process, and we are continuing to evaluate how well it aligns with the judgements of human reviewers on this call. We will soon produce a document detailing our method, so that others can build upon it and improve it.

Feedback on your application

Your application was not selected to progress beyond the AI triage stage.  To provide transparency on the outcome of this assessment, we are sharing below the scores (out of 5) from each of the two AI review processes described above, together with the mean score across the two processes.
40430236
Reposted by Colm Ryan
Traver Hart @traver.bsky.social · 22/09/2026
Hi everyone. We have substantially improved our genetic interactions manuscript. Take a look here: www.biorxiv.org/content/10.6...
biorxiv.org
Functional modules predict genetic interactions, revealing evolutionary conservation and rewiring
Genetic interactions can reveal gene function and identify disease-relevant synthetic lethals, but resource-intensive screening in human cells constrains experimental scope and limits our understandin...
122
Colm Ryan @colmr.bsky.social · 22/09/2026
Narod's paper on a predicted cancer dependency map for paralog pairs is out now in Genome Medicine. We use existing @depmap.org single gene CRISPR screens + cell line molecular profiles as features to predict paralog pair vulnerabilities across >1000 cell lines link.springer.com/article/10.1...
link.springer.com
Systematic prioritisation of context-specific paralog pair vulnerabilities in cancer - Genome Medicine
Background Genome-wide CRISPR screening has enabled the development of dependency maps in hundreds of cancer cell lines, facilitating the identification of genetic vulnerabilities associated with spec...
041
Reposted by Colm Ryan
Sergey Ovchinnikov @sokrypton.org · 14/09/2026
Finally a more intuitaive way to learn pLDDT/pAE? 😎 sokrypton.github.io/protein_figh... (Character idea from @hannes-stark.bsky.social & Alex Waldherr)
727698
Colm Ryan @colmr.bsky.social · 04/09/2026
Bernard came back from his placement @ebi.embl.org bearing gifts...
Sticker from the Perturbation Catalogue stating "Would I rather catalogue a thousand perturbations once or one perturbation a thousand times? Easy. Both."
020
Reposted by Colm Ryan
bioRxivpreprint @biorxivpreprint.bsky.social · 22/08/2026
A survey of multi-targeting and off-targeting sgRNAs across five genome-wide CRISPR-Cas9 knockout sgRNA libraries with GuideRefine www.biorxiv.org/content/10.64898/20…
031
Colm Ryan @colmr.bsky.social · 28/07/2026
more complexity in translating synthetic lethal interactions. "interactions observed in vector-based models are often a consequence of IDHmut protein overexpression..." www.sciencedirect.com/science/arti...
sciencedirect.com
Targeting vulnerabilities in IDH mutant tumours: The model matters
Synthetic lethal interactions with IDH1 and IDH2 (IDH) mutations were identified in non-endogenous IDH mutant (IDHMUT) AML and glioma models, but are …
000
Reposted by Colm Ryan
Sarah Aitken @s-j-aitken.bsky.social · 27/07/2026
🧬NEW PAPER🧬 To what extent is cancer development deterministic? Does the germline genome affect that predictability? Find out in our #StrainDifferences paper @nature.com "Genetic background sets the trajectory of experimental cancer evolution" www.nature.com/articles/s41... 🧵[1/14]
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
14717
Reposted by Colm Ryan
Eric Conway @conwayer1.bsky.social · 27/07/2026
Preprint alert! 🚨 We are very excited to share our new manuscript on Bohring-Opitz syndrome, a devastating rare monogenic disorder driven by truncating variants in ASXL1. This project was led by PhD student Emma Doyle, one of the OG Conway lab members 💪. 1/6 www.biorxiv.org/content/10.6...
biorxiv.org
Divergent Pathogenic PR-DUB Complex Variants Converge Functionally Via PRC2 Displacement From Chromatin
The PR-DUB complex is responsible for erasing the repressive histone modification, H2AK119ub1. ASXL1-3 proteins are mutually exclusive catalytic partners of BAP1 in the PR-DUB complex. Somatic heteroz...
41512
Reposted by Colm Ryan
Lars Juhl Jensen @larsjuhljensen.bsky.social · 22/07/2026
Benchmarks of AI agentic systems remind me of bioinformatics 20 years. And not in a good way! Is anyone else getting tired of everyone reporting that they are better than everyone else according to their own new benchmark? 🤬
3122
Reposted by Colm Ryan
John Doench @johndoench.bsky.social · 06/07/2026
New preprint from the group, comparing CRISPRko and CRISPRi via a Perturb-seq readout: www.biorxiv.org/content/10.6...
biorxiv.org
Direct comparison of CRISPR knockout and interference with Perturb-seq
CRISPR knockout (CRISPRko) and CRISPR interference (CRISPRi) are two workhorse technologies for loss-of-function studies, yet direct comparisons between the two are scant relative to their widespread ...
14117
Reposted by Colm Ryan
University College Dublin @ucddublin.bsky.social · 15/07/2026
💙💛 Our warmest congratulations to UCD Professor Cormac Taylor, who has been named the recipient of The Physiological Society’s 2027 Widening Participation in Physiology Prize Lecture.
141
Colm Ryan @colmr.bsky.social · 14/07/2026
With lab members from both France and Spain, I have to hope for an unprecedented draw in this evening’s semifinal. Perhaps both teams will shake hands, acknowledge how good they both are, and then go for a celebratory smoothie.
030
Colm Ryan @colmr.bsky.social · 13/07/2026
Nicely caveated science reporting from the Guardian – 'Thirty is pretty arbitrary', 'scientists still don’t know exactly what a “healthy” microbiome looks like' www.theguardian.com/lifeandstyle...
theguardian.com
Is it true that … we should eat 30 plants a week?
A growing supplements market may be trying to capitalise on this claim, but the truth is we still don’t know what a truly healthy gut microbiome really looks like
010
Reposted by Colm Ryan
James Gahan @jgahan.bsky.social · 22/06/2026
Very saddened to learn that @wellcometrust.bsky.social has decided to no longer fund Irish researchers through their discovery grants. This is a major blow for those who do truly blue skies research in Ireland as the ecosystem (i.e. @researchireland.ie) only funds research with perceived "impact"!
3189
Colm Ryan @colmr.bsky.social · 10/06/2026
Another genetic interaction map of the DNA Damage Response. That makes six maps now! www.biorxiv.org/content/10.6...
biorxiv.org
Mapping the genetic landscape of the DNA damage response with Cas12a-based combinatorial knockout screens
The DNA damage response (DDR) is a complex network of cellular pathways that ensures the faithful maintenance of our genomes upon a wide array of genomic insults. To elucidate the functional architect...
021
Reposted by Colm Ryan
Rob Kitchin @robkitchin.bsky.social · 04/06/2026
My letter to Minister Lawless about Research Ireland's decision to devolve the awarding of doctoral scholarships & postdoctoral fellowships to universities. A disastrous move. Please consider raising this issue in your own institutions and with elected representatives and the media.
03128
Reposted by Colm Ryan
Máire Ní Leathlobhair @mnileathlobhair.bsky.social · 25/05/2026
Now out in Genome Medicine link.springer.com/article/10.1... Work led by the brilliant Elle Loughran (not on bsky) on the evolution of hypodiploid tumours, who is heading to Montpellier this week to start a postdoc with @aline-muyle.bsky.social!
063
Reposted by Colm Ryan
Ran Blekhman @blekhman.bsky.social · 17/05/2026
Some thoughts on where AI in genomics stands right now, building on a symposium we recently hosted at UChicago. Seven points, ranging from why scaling DNA models hasn't delivered, to why metadata is the real bottleneck, to the weird backlash against AI in academia open.substack.com/pub/blekhman...
open.substack.com
Seven points on the current state of AI in genomics
A grounded take from the messy middle of an AI revolution
46825
Colm Ryan @colmr.bsky.social · 12/05/2026
Thinking about applying for an MSCA postdoctoral fellowship? The UCD School of Medicine has a list of academics keen to support applicants. I'm one – looking for people interested in synthetic lethality, paralogs in disease, or LLMs for genotype-phenotype analysis. www.ucd.ie/medicine/res...
ucd.ie
EoI for MSCA Postdoctoral Fellowships - UCD School of Medicine
030
Reposted by Colm Ryan
Chris Lord and Andrew Tutt’s Lab Institute of Cancer Research @icrlordlab.bsky.social · 06/05/2026
If you are interested in PARP inhibitors and history, this might be of interest to you. www.nature.com/articles/s41.... An attempt to cover the work of thousands and their immense contributions to the development of a targeted approach to treating cancers.
nature.com
Two decades of PARP inhibitor synthetic lethality in cancer - Nature
The past two decades of PARP inhibitor synthetic lethality in cancer is explored.
01510
Reposted by Colm Ryan
Pedro Beltrao @pedrobeltrao.bsky.social · 04/03/2026
We have started a project trying to predic the interactions/structures of all yeast protein pairs using an AlphaFold pooling approach. We are making the current dataset open and we welcome collaborations. www.evocellnet.com/2026/03/mapp...
evocellnet.com
Mapping the yeast atructural interactome with AlphaFold3: an open call for collaboration
We are excited to announce the early-stage release of our S. cerevisiae  structural interactome mapping project. Using AlphaFold3 (AF3), w...
69853
Reposted by Colm Ryan
Manuel Kaulich @manuelkaulich.bsky.social · 24/02/2026
Our thoughts, impressions, and presentations of the "2nd EuroDepMap symposium" in Milan (Nov 2025) are online at @febsletters.bsky.social. febs.onlinelibrary.wiley.com/doi/10.1002/...
febs.onlinelibrary.wiley.com
FEBS Press
Held on 20 November 2025 at Human Technopole in Milan, the 2nd European Cancer Dependency Map Symposium convened experimental and computational scientists to discuss how cancer dependency mapping in ...
058
Reposted by Colm Ryan
Daniela Robles-Espinoza @daniela-oaks.bsky.social · 18/02/2026
We are very happy to see our study finally appear online @nature.com! This has been work of nearly 10 years in collaboration with the National Institute of Genome Medicine 🇲🇽, the National Cancer Institute 🇲🇽, the @sangerinstitute.bsky.social and others ⬇️ www.nature.com/articles/s41...
nature.com
Ancestry and somatic profile indicate acral melanoma origin and prognosis - Nature
Analysis of the somatic and transcriptomic profile of 123 acral melanoma samples from Mexican patients helps understand tumour origins and prognosis, and highlights the importance of including samples...
149141
Reposted by Colm Ryan
Evangelia Petsalaki @epetsalaki.bsky.social · 19/02/2026
Our preprint is now published in MSB. link.springer.com/article/10.1... We decompose multi-omics into distinct phenotypic axes (drug response vs ARID1A-driven cell state), improving interpretation and revealing how baseline cell state rewires signaling and shapes MAPK inhibitor resistance.
link.springer.com
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms - Molecular Systems Biology
Resistance to BRAF/MAPK inhibitors is a significant challenge in melanoma treatment, driven by adaptive and acquired mechanisms allowing tumor cells to evade therapy. We explored early signaling respo...
153
Reposted by Colm Ryan
Maximilian Billmann @maxbillmann.bsky.social · 04/02/2026
And more isogenic CRISPR screens coming out of Toronto @sickkidsto.bsky.social, this time by Mike Tyers and team - congrats! www.biorxiv.org/content/10.6...
biorxiv.org
131
Colm Ryan @colmr.bsky.social · 03/02/2026
starting to suspect that we won't hear the outcome of the Research Ireland Investigators Stage 1 call by the end of January
020
Colm Ryan @colmr.bsky.social · 29/01/2026
New paper from Narod Kebabci – “A predicted cancer dependency map for paralog pairs” www.biorxiv.org/content/10.6... Background: The Cancer Dependency Map from @depmap.org is a fantastic resource that characterises genetic dependencies at genome-wide scale across ~1,000 cancer cell lines. 1/9
biorxiv.org
A predicted cancer dependency map for paralog pairs
Background Genome-wide CRISPR screening has enabled the development of dependency maps in hundreds of cancer cell lines, facilitating the identification of genetic vulnerabilities associated with specific biomarkers. Paralogs, despite being common drug targets, are often missed in these screens as their individual disruption rarely causes a significant fitness defect. Combinatorial screens have revealed that paralog pairs are often synthetic lethal but that these effects are highly context specific. To develop paralogs as therapeutic targets we must identify which paralog pairs are synthetic lethal in which cancer contexts. Results We develop a machine learning classifier to predict cell-line specific synthetic lethality between paralog pairs. We demonstrate the utility of features derived from the cell-line specific expression and essentiality of the pair and their protein-protein interaction partners for this purpose. We evaluate our predictions across multiple scenarios: predicting for the same pairs in unseen cell lines, for new gene pairs in seen cell lines, and for entirely uncharacterized pairs in unseen cell lines. We show that we can make predictions across all scenarios. We validate our predictions using independent combinatorial CRISPR screens and show that the agreement between our predictions and published experiments approaches the agreement across experiments. Conclusions Our classifier predicts cell-line-specific synthetic lethality between paralog pairs and provides insights into the underlying features driving these interactions. We make our predictions for 1,005 cell lines available as a resource to facilitate the discovery of context-specific paralog synthetic lethalities and to guide the design of more targeted combinatorial screens. ### Competing Interest Statement The authors have declared no competing interest. Research Ireland, 20/FFP-P/8641, 18/CRT/6214
133
Colm Ryan @colmr.bsky.social · 23/01/2026
Another genetic interaction map of DNA repair factors! I think that makes 5 GI maps (including preprints) of DNA Damage / Repair related factors? Potentially enough to do some systematic comparisons. www.sciencedirect.com/science/arti...
sciencedirect.com
Uncovering genetic interactions in the DNA repair network in response to endogenous damage and ionizing radiation
Genomic integrity relies on a complex network of DNA damage response (DDR) pathways that repair endogenous and exogenous lesions, yet how individual f…
120
Reposted by Colm Ryan
Maximilian Billmann @maxbillmann.bsky.social · 23/01/2026
Great new work from @colmr.bsky.social predicts a cancer dependency map for paralogs: doi.org/10.64898/202....
doi.org
111
Reposted by Colm Ryan
Thomas Norman @normanlab.bsky.social · 20/01/2026
New preprint on technologies to scale up CRISPR screens. We use them to map 665,856 pairwise genetic perturbations and outline a path to comprehensive interaction mapping in human cells. We also introduce an approach for cloning lentiviral libraries with billions of elements.
29242
Reposted by Colm Ryan
Steven Salzberg @stevensalzberg.bsky.social · 16/01/2026
very sad news. Peer Bork was one of the leaders of our field, a wonderful scientist, and he's much too young to be gone. www.embl.org/news/embl-an...
embl.org
In remembrance of Peer Bork  | EMBL
EMBL and its community are deeply saddened by the death of Peer Bork, the organisation’s Interim Director General.
1014581
Colm Ryan @colmr.bsky.social · 09/01/2026
Enjoying 'Why Machines Learn' by Anil Ananthaswamy, including this anecdote highlighting that there's always more that *could* be in a PhD but that you have to draw a line somewhere. Guyon here is Isabelle Guyon, who was later key to the development of SVMs (especially the kernel trick)
Photo containing the following text: "Their paper was published a year before Guyon defended her Ph.D. thesis, for which she had tested numerous algorithms for linear classification—but none of these was an optimal margin classifier, meaning the algorithms found some linear boundary, not necessarily the best one. Guyon could have used Krauth and Mézard's algorithm to implement an optimal margin classifier; she didn't. "One of the examiners of my Ph.D. asked me why I did not implement the algorithm of Mézard and Krauth and benchmark it against the other things I was trying. I said, 'Well, I didn't think it would make that much of a difference,'" Guyon told me. "But the reality is that I just wanted to graduate, and I didn't have time."
010
Reposted by Colm Ryan
Traver Hart @traver.bsky.social · 21/12/2025
Merry Christmas, genetic interaction nerds: www.biorxiv.org/content/10.6...
biorxiv.org
Functional modules predict cancer-relevant genetic interactions in mammalian cells
Genetic interactions can reveal gene function and identify cancer-relevant synthetic lethals, but systematic mapping in human cells is constrained by inefficient reagents, vast combinatorial search sp...
2219
Colm Ryan @colmr.bsky.social · 05/12/2025
Great to see this out, collaboration with the Bond lab @sysbioire.bsky.social to understand consequences of EZH2 mutation in T-acute lymphoblastic leukaemia (T-ALL). Congrats to @lefeivret.bsky.social @cosmintudose.bsky.social and other authors not on bluesky! ashpublications.org/bloodadvance...
ashpublications.org
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity
Key Points. Reduced PRC2 function in T-ALL is associated with asparaginase resistance that is linked to reduced WNT/STOP pathway activity.Asparaginase resi
031
Colm Ryan @colmr.bsky.social · 28/11/2025
Replacing my still functioning 2017 Mac because it's no longer compatible with our two factor authentication software (preventing me logging on to any work related system). This really doesn't seem optimal.
000
Reposted by Colm Ryan
Evangelia Petsalaki @epetsalaki.bsky.social · 26/11/2025
#Postdoc alert! We are looking for motivated individual with experience in computational systems biology to join our NetworkCommons initiative to benchmark and democratise network contextualisation methods across multiple applications. Deadline Dec 17th link here: tinyurl.com/yrrzxa94
tinyurl.com
Postdoctoral fellow - Petsalaki Group - NetworkCommons
Your group The Petsalaki, Saez-Rodriguez (EMBL-EBI) and Korcsmáros (Imperial College) groups develop cutting-edge computational and AI approaches to unravel cellular signalling and gene regulation fro...
159
Reposted by Colm Ryan
Francesco Iorio @francescoiorio.bsky.social · 03/11/2025
Last chance to register. Hurry Up!
131
Reposted by Colm Ryan
Darren Dahly @statsepi.bsky.social · 24/10/2025
Anyone with a lower h-index than me is ineffectual, while anyone with a higher h-index is just better at playing the game and cutting corners. I'm sorry, that's just how numbers work!
1304
Reposted by Colm Ryan
James Nolan @jamesnolan.bsky.social · 17/10/2025
🧵1/Exciting news in cancer epigenetics! Our latest research, "AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma", is now available on www.biorxiv.org/content/10.1.... Here's a thread summarizing our findings!👇 #CancerResearch #Epigenetics #Chromatin #Lymphoma
biorxiv.org
AEBP2-Directed H3K27me2 Defines a Specific Vulnerability in EZH2-mutant Lymphoma
The catalytic subunit of Polycomb Repressive Complex 2 (PRC2), EZH2, is recurrently mutated in 25% of diffuse large B-cell lymphomas (DLBCL), causing increased H3K27me3 and decreased H3K27me2 levels. ...
12310
Reposted by Colm Ryan
Claus Wilke @clauswilke.com · 07/10/2025
Biology is much more complicated than most non-biologists can imagine. And AI is not going to change this anytime soon. blog.genesmindsmachines.com/p/we-still-c...
blog.genesmindsmachines.com
We still can’t predict much of anything in biology
Biology is hard. Yes, even for AI.
517167
Colm Ryan @colmr.bsky.social · 29/09/2025
Hamda's paper is out: benchmarking different genetic interaction scoring methods for identifying synthetic lethal interactions from combinatorial CRISPR screens. academic.oup.com/nargab/artic...
academic.oup.com
Benchmarking genetic interaction scoring methods for identifying synthetic lethality from combinatorial CRISPR screens
Abstract. Synthetic lethality (SL) is an extreme form of negative genetic interaction, where simultaneous disruption of two non-essential genes causes cell
120
Colm Ryan @colmr.bsky.social · 24/09/2025
Enjoyed writing this review of synthetic lethality in drug discovery with @emanuelvgo.bsky.social and @davidjadams.bsky.social rdcu.be/eFBmw
rdcu.be
Synthetic lethality in cancer drug discovery: challenges and opportunities
Nature Reviews Drug Discovery - This Review outlines recent advances in synthetic lethality, from CRISPR-based discovery and machine learning-guided prioritization of gene pairs to new phenotypic...
051
Reposted by Colm Ryan
Chris Lord and Andrew Tutt’s Lab Institute of Cancer Research @icrlordlab.bsky.social · 19/09/2025
We're hiring ! Specifically....we are seeking to appoint a creative and motivated Postdoctoral Training Fellow to study how drug resistance emerges in homologous recombination defective (HRD) breast cancers and how this could be targeted. jobs.icr.ac.uk/vacancies/13...
jobs.icr.ac.uk
PDTF - Homologous Recombination Defective Cancers ( Profs Chris Lord and Andrew Tutt) in Chelsea | The Institute of Cancer Research
View details and apply for this PDTF - Homologous Recombination Defective Cancers ( Profs Chris Lord and Andrew Tutt) vacancy in Chelsea . Salary: Dependent on relevant Postdoctoral exp...
194
Reposted by Colm Ryan
Francesco Iorio @francescoiorio.bsky.social · 17/09/2025
📢 The 2nd European Cancer Dependency Map Symposium is coming! 🗓️ 20 Nov 2025 📍 Human Technopole, Milan Join us for a one-day dive into: 🔹 Cancer genomics 🔹 CRISPR screening 🔹 AI-driven target discovery With the patronage of AIRC 🔗 humantechnopole.it/en/trainings...
humantechnopole.it
2nd European Cancer Dependency Map Symposium - Human Technopole
The 2nd European Cancer Dependency Map Symposium is a scientific event open to the national and international scientific community working in computational genomics, pharmacogenomics, and therapeutic ...
033
Reposted by Colm Ryan
Francesco Iorio @francescoiorio.bsky.social · 11/09/2025
Join Us! @ioriolab.bsky.social
001
Reposted by Colm Ryan
Cosmin Tudose @cosmintudose.bsky.social · 09/09/2025
Pleased that the 2nd part of my PhD is now available as a preprint! Here, we investigated the epigenomic and transcriptomic changes occurring upon PRC2 depletion in AML cells. biorxiv.org/content/10.1.... A thread🧵1/17
biorxiv.org
Diverse epigenomic mechanisms underpin transcriptional dysregulation in Polycomb-altered acute myeloid leukemia
Background Polycomb Repressive Complex 2 (PRC2) modulates chromatin accessibility and architecture to direct tissue-specific gene expression. PRC2 function is frequently altered in cancer by loss-of-f...
152